Suppressing CDC20 (depletion of endogenous or pharmacological inhibitors) in diverse cancer cell lines led to a mitotic arrest and apoptosis, suggesting targeting CDC20 might be a novel anti-cancer therapy, especially in cancer with high expression (69). Here, CDC20 is linked to cancer.